People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CIRC Biosciences, Inc. | — | Biotechnology | Series B | $24.1M | $54.7M | 2020 |
Sai J. Chavala at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sai J. Chavala on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Antonio Gracias | 1 | 15 |
| Patrick J. Morris | 1 | 8 |
| Darien J. Parhad | 1 | 7 |
| Antonio J. Gracias | 1 | 7 |
| Jeffrey Aronin | 1 | 6 |
| Patrick Morris | 1 | 6 |
| Timothy Cunniff | 1 | 5 |
| Darien Parhad | 1 | 4 |
| Jeffrey S. Aronin | 1 | 4 |
| Timothy M. Cunniff | 1 | 2 |
| Sai Chavala | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.